Literature DB >> 17322386

Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis.

Gwo-Hsiao Chen1, Michal A Olszewski, Roderick A McDonald, Jason C Wells, Robert Paine, Gary B Huffnagle, Galen B Toews.   

Abstract

We investigated the role of granulocyte macrophage colony-stimulating factor (GM-CSF) in host defense in a murine model of pulmonary cryptococcosis induced by intratracheal inoculation of Cryptococcus neoformans. Pulmonary C. neoformans infection of C57BL/6 mice is an established model of an allergic bronchopulmonary mycosis. Our objective was to determine whether GM-CSF regulates the pulmonary Th2 immune response in C. neoformans-infected C57BL/6 mice. Long-term pulmonary fungistasis was lost in GM-CSF knockout (GM(-/-)) mice, resulting in increased pulmonary burden of fungi between weeks 3 and 5. GM-CSF was required for the early influx of macrophages and CD4 and CD8 T cells into the lungs but was not required later in the infection. Lack of GM-CSF also resulted in reduced eosinophil recruitment and delayed recruitment of mononuclear cells into the airspace. Macrophages from GM(+/+) mice showed numerous hallmarks of alternatively activated macrophages: higher numbers of intracellular cryptococci, YM1 crystals, and induction of CCL17. These hallmarks are absent in macrophages from GM(-/-) mice. Mucus-producing goblet cells were abundantly present within the bronchial epithelial layer in GM(+/+) mice but not in GM(-/-) mice at week 5 after infection. Production of both Th1 and Th2 cytokines was impaired in the absence of GM-CSF, consistent with both reduced C. neoformans clearance and absence of allergic lung pathology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17322386      PMCID: PMC1864884          DOI: 10.2353/ajpath.2007.060595

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  59 in total

1.  Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans.

Authors:  G B Huffnagle; G B Toews; M D Burdick; M B Boyd; K S McAllister; R A McDonald; S L Kunkel; R M Strieter
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

2.  Lanoconazole, a new imidazole antimycotic compound, protects MAIDS mice against encephalitis caused by Cryptococcus neoformans.

Authors:  K Furukawa; H Sasaki; R B Pollard; F Suzuki
Journal:  J Antimicrob Chemother       Date:  2000-09       Impact factor: 5.790

3.  Identification of R146225 as a novel, orally active inhibitor of interleukin-5 biosynthesis.

Authors:  J Van Wauwe; F Aerts; M Cools; F Deroose; E Freyne; J Goossens; B Hermans; J Lacrampe; H Van Genechten; F Van Gerven; G Van Nyen
Journal:  J Pharmacol Exp Ther       Date:  2000-11       Impact factor: 4.030

4.  The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection.

Authors:  M A Olszewski; G B Huffnagle; R A McDonald; D M Lindell; B B Moore; D N Cook; G B Toews
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

Review 5.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors:  T G Mitchell; J R Perfect
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice.

Authors:  K A Hoag; N E Street; G B Huffnagle; M F Lipscomb
Journal:  Am J Respir Cell Mol Biol       Date:  1995-10       Impact factor: 6.914

7.  The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection.

Authors:  G B Huffnagle; R M Strieter; T J Standiford; R A McDonald; M D Burdick; S L Kunkel; G B Toews
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

8.  Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.

Authors:  G Dranoff; A D Crawford; M Sadelain; B Ream; A Rashid; R T Bronson; G R Dickersin; C J Bachurski; E L Mark; J A Whitsett
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

9.  Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa.

Authors:  Megan N Ballinger; Robert Paine; Carlos H C Serezani; David M Aronoff; Esther S Choi; Theodore J Standiford; Galen B Toews; Bethany B Moore
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-10       Impact factor: 6.914

10.  Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans.

Authors:  G B Huffnagle; G H Chen; J L Curtis; R A McDonald; R M Strieter; G B Toews
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

View more
  39 in total

1.  TLR4-dependent GM-CSF protects against lung injury in Gram-negative bacterial pneumonia.

Authors:  Louis R Standiford; Theodore J Standiford; Michael J Newstead; Xianying Zeng; Megan N Ballinger; Melissa A Kovach; Ajaya K Reka; Urvashi Bhan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-09       Impact factor: 5.464

Review 2.  Induction of protective immunity against cryptococcosis.

Authors:  Karen L Wozniak; Sarah Hardison; Michal Olszewski; Floyd L Wormley
Journal:  Mycopathologia       Date:  2011-12-06       Impact factor: 2.574

3.  Rat eosinophils stimulate the expansion of Cryptococcus neoformans-specific CD4(+) and CD8(+) T cells with a T-helper 1 profile.

Authors:  Ana P Garro; Laura S Chiapello; José L Baronetti; Diana T Masih
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

4.  Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome.

Authors:  Shuli Bonham; David B Meya; Paul R Bohjanen; David R Boulware
Journal:  Biomark Med       Date:  2008       Impact factor: 2.851

5.  Autoantibody-Mediated Pulmonary Alveolar Proteinosis in Rasgrp1-Deficient Mice.

Authors:  Andrew Ferretti; Jarrod R Fortwendel; Sarah A Gebb; Robert A Barrington
Journal:  J Immunol       Date:  2016-06-08       Impact factor: 5.422

6.  Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production.

Authors:  Benjamin J Murdock; Gary B Huffnagle; Michal A Olszewski; John J Osterholzer
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

7.  Candida glabrata persistence in mice does not depend on host immunosuppression and is unaffected by fungal amino acid auxotrophy.

Authors:  I D Jacobsen; S Brunke; K Seider; T Schwarzmüller; A Firon; C d'Enfért; K Kuchler; B Hube
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

8.  Paradoxical role of alveolar macrophage-derived granulocyte-macrophage colony-stimulating factor in pulmonary host defense post-bone marrow transplantation.

Authors:  Megan N Ballinger; Leah L N Hubbard; Tracy R McMillan; Galen B Toews; Marc Peters-Golden; Robert Paine; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

9.  IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis.

Authors:  Werner Stenzel; Uwe Müller; Gabriele Köhler; Frank L Heppner; Manfred Blessing; Andrew N J McKenzie; Frank Brombacher; Gottfried Alber
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

10.  Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection.

Authors:  Sarah E Hardison; Sailatha Ravi; Karen L Wozniak; Mattie L Young; Michal A Olszewski; Floyd L Wormley
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.